An international team of researchers led by the University of California San Diego has developed a new strategy to enhance ...

Scientists have made 'exciting,' patient-friendly advances in developing a non-toxic bacterial therapy, BacID, to deliver cancer-fighting drugs directly into tumors. This emerging technology holds ...

Cancer remains a leading cause of death globally, with breast cancer being the most fatal for women. A recent American Cancer ...

If you could take a simple blood test that could detect multiple types of cancer while they’re still in an early and ...

It’s a sobering statistic: 1 in 8 women in the United States will be diagnosed with breast cancer during her lifetime.1 ...

IMPACT Therapeutics ("IMPACT"), a biopharmaceutical company focusing on the discovery and development of targeted anti-cancer therapeutics based on synthetic lethality, is pleased to announce ...

Information on tumor mutational status was limited before the development of NGS because traditional Sanger sequencing and ...

NHS Shared Business Services has issued a tender worth £150m, split into six lots, covering the use of artificial ...

TG Therapeutics said it is working to develop a subcutaneous (under-the-skin) version of relapsing MS therapy Briumvi.

The Kansas City Zoo & Aquarium said goodbye to a long-time inhabitant and "gentle giant" of a snake. The zoo announced the death of its 26-year-old leucistic Burmese python on Friday. She died of ...

New Zealand headquartered soft tissue regeneration company Aroa Biosurgery recently announced the publication of further strong clinical evidence reinforcing both efficacy and cost benefits of its ...